Misunderstanding regarding the carboplatin dose comparison in MRC TE19/EORTC 30982.

Lipshitz, Jay

Misunderstanding regarding the carboplatin dose comparison in MRC TE19/EORTC 30982. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2011 - 4211; author reply 4211-2 p. digital

Publication Type: Letter; Comment

1527-7755

10.1200/JCO.2011.36.1840 doi


Antineoplastic Agents--therapeutic use
Carboplatin--therapeutic use
Humans
Male
Orchiectomy
Seminoma--therapy
Testicular Neoplasms--therapy